We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

MorphoSys Announces Clinical Milestone in Ophthalmology Program

News   May 03, 2013

 
MorphoSys Announces Clinical Milestone in Ophthalmology Program
 
 
Advertisement
 

RELATED ARTICLES

New Cancer Vaccine Ready for Human Trials

News

A new cancer vaccine, comprised of human antibodies fused with tumor-specific protein, is ready to begin human testing.

READ MORE

A Mirror-image Peptide Tumor Treatment

News

Scientists have developed a new approach to immunological tumor treatment. Their method is based on the specific blockade of an immune checkpoint by a stable "mirror-image" peptide.

READ MORE

Accelerated Discovery of Bioactive Components in Seaweed

News

Using state-of-the-art approaches coupled with bio- and cheminformatics and machine learning, researchers at the GEOMAR Helmholtz Centre for Ocean Research Kiel have succeeded in discovering new, bioactive components of the Baltic Sea seaweed Fucus vesiculosus and its fungal symbiont against infectious bacteria or skin cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE